rethinkPeptides Search
Menu
Research citation

Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction.

Med (New York, N.Y.), 6(2), 100570

Citation

Hellenkamp, Kristian; Sato, Ryosuke; von Haehling, Stephan. (2025). Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction.. Med (New York, N.Y.), 6(2), 100570. https://doi.org/10.1016/j.medj.2024.12.004